Woods Keith
SEC insider (Form 3/4/5 filer). CIK 0001996804. Chief Operating Officer at Scholar Rock Holding Corp (SRRK) and 3 other issuers. 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 24, 2026. Located in CAMBRIDGE, MA.
Companies Woods Keith has filed insider reports for
- Scholar Rock Holding Corp (SRRK): Officer, Chief Operating Officer
- Neurogene Inc. (NGNE): Director
- TScan Therapeutics, Inc. (TCRX): Director
- X4 Pharmaceuticals, Inc (XFOR): Director
Woods Keith
CIK: 0001996804
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 24, 2026SRRK
Scholar Rock Holding Corp
GiftDirect48K shares- - May 20, 2026TCRX
TScan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
67K shares- - Apr 16, 2026SRRK
Scholar Rock Holding Corp
SaleDirect10.2K shares at avg. $49.57$507K - Feb 20, 2026NGNE
Neurogene Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
12.1K shares- - Feb 9, 2026SRRK
Scholar Rock Holding Corp
AwardDirect47K shares- - Jan 13, 2026SRRK
Scholar Rock Holding Corp
SaleDirect16.7K shares at avg. $42.70$715K - Jun 30, 2025TCRX
TScan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
67K shares- - Jun 12, 2025NGNE
Neurogene Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
12.1K shares- - Jun 9, 2025XFOR
X4 Pharmaceuticals, Inc
AwardDirect1.5K shares- - May 2, 2025SRRK
Scholar Rock Holding Corp
AwardDirectStock Option (Right to Buy)
110.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 |  SRRK Scholar Rock Holding Corp | Gift | 48,034 | - | $0 | Direct |
| May 20, 2026 |  TCRX TScan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Apr 16, 2026 | SRRK Scholar Rock Holding Corp | Sale | 10,220 | $49.57 | $506,651 | Direct |
| Feb 20, 2026 |  NGNE Neurogene Inc. | Award Non-Qualified Stock Option (right to buy) | 12,050 | - | - | Direct |
| Feb 9, 2026 | SRRK Scholar Rock Holding Corp | Award | 47,021 | - | $0 | Direct |
| Jan 13, 2026 | SRRK Scholar Rock Holding Corp | Sale | 16,746 | $42.70 | $715,054 | Direct |
| Jun 30, 2025 | TCRX TScan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 67,000 | - | - | Direct |
| Jun 12, 2025 | NGNE Neurogene Inc. | Award Non-Qualified Stock Option (right to buy) | 12,050 | - | - | Direct |
| Jun 9, 2025 |  XFOR X4 Pharmaceuticals, Inc | Award | 1,500 | - | - | Direct |
| May 2, 2025 | SRRK Scholar Rock Holding Corp | Award Stock Option (Right to Buy) | 110,067 | - | - | Direct |
1-10 of 14 transactions